Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andrea L Cote
Observed names:
Andrea Cote,
Andrea L. Cote
Institutions:
Ragon Institute of MGH, MIT and Harvard,
Mass General Brigham,
Massachusetts Institute of Technology
Observed institutions:
University of New Hampshire,
Ragon Institute of MGH, MIT and Harvard,
Koch Institute for Integrative Cancer Research At MIT,
Mass General Brigham,
Massachusetts Institute of Technology
ORCID:
0000-0002-8200-3744
Observed ORCID:
0000-0002-8200-3744
OpenAlex ID:
A5027544375
Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia
2019
·
Brian M. Barth
, Weiyuan Wang
, et al.
·
Blood Advances
·
37
PDF
Emerging insights into the impact of systemic metabolic changes on tumor-immune interactions
2025
·
Andrea L. Cote
, Chad J. Munger
, et al.
·
Cell Reports
·
29
The Role of Ceramide and Sphingolipid Metabolism in Cancer Therapeutics
2025
·
Andrea L. Cote
, Kyla S. Jarvis
, et al.
·
Journal of Oncology Research and Therapy
·
4
PDF
GDF1 Regulation of Ceramide Metabolism Restores Effective Hematopoiesis in Myelodysplastic Syndrome
2019
·
Brian Barth
, Weiyuan Wang
, et al.
·
Blood
·
2
Obesity Promotes the Ceramide-Mediated NADPH Oxidase in Acute Myeloid Leukemia.
2024
·
Weiyuan Wang
, Rachel J Sabol
, et al.
·
PubMed
·
1
PDF
GDF1 Is a Regulator of Sphingolipid Metabolism in Acute Myeloid Leukemia
2019
·
Weiyuan Wang
, Emily Sullivan
, et al.
·
Blood
·
1
Citrate Compartmentalization Controls Calcium-Dependent Cytokine Production in Effector T Cells
2026
·
Andrea L. Cote
, Claire L. McIntyre
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
The Role of the Microbiome in Cancer and the Development of Cancer Therapeutics.
2020
·
Kaitlyn C Belknap
, Andrea L Cote
, et al.
·
PubMed
Show more works
View as search
Works count:
8
Citation count:
74
H-index:
3
I10-index:
2
Year
Topic
Type